GENEVA, July 9 -- SHENYANG PHARMACEUTICAL UNIVERSITY filed a patent application (CN2025/144262) for “2,4-DIAMINOPYRIMIDINE COMPOUND AND USE THEREOF”. With publication no. WO/2026/145098, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07D 401/14
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....